Harfst & Associates’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-476	Closed	-$221K	–	98
2024 Q3	$221K	Sell	476 -546	-53%	-$262K	0.05%	91
2024 Q2	$479K	Hold	1,022	–	–	0.11%	80
2024 Q1	$427K	Sell	1,022 -14	-1%	-$5.92K	0.1%	85
2023 Q4	$422K	Hold	1,036	–	–	0.11%	68
2023 Q3	$360K	Hold	1,036	–	–	0.1%	75
2023 Q2	$365K	Sell	1,036 -1,174	-53%	-$396K	0.1%	77
2023 Q1	$696K	Sell	2,210 -7	-0.3%	-$2.1K	0.2%	74
2022 Q4	$640K	Sell	2,217 -43	-2%	-$13.1K	0.18%	76
2022 Q3	$654K	Sell	2,260 -21	-0.9%	-$6.04K	0.2%	74
2022 Q2	$642K	Sell	2,281 -22	-1%	-$5.89K	0.18%	78
2022 Q1	$601K	Buy	2,303 +405	+21%	+$96.1K	0.14%	94
2021 Q4	$416K	Sell	1,898 -1,189	-39%	-$231K	0.11%	97
2021 Q3	$559K	Sell	3,087 -109	-3%	-$21.3K	0.15%	95
2021 Q2	$644K	Buy	3,196 +78	+3%	+$16.3K	0.19%	91
2021 Q1	$670K	Buy	+3,118	New	+$685K	0.2%	93